Apollomics Inc

Biotech Stocks Healthcare Stocks

$19.25

+0.65 (+3.49%)

As of Feb 8, 2:24 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target -35.6% upside

Low Target $7.78

Average Target $12.39

High Target $16.73

Current Price $19.25

Current
$19.25

Target
$12.39

$7.78 $12.39 avg $16.73

Scenario Analysis

Bear Case

$7.78

-59.6%

Low target

Base Case

$12.39

-35.6%

Avg target

Bull Case

$16.73

+-13.1%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$12.11

59.0% from high

52-Week Low

$7.68

+150.7% from low

Target vs 52W High

$12.39

+2.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%